🇺🇸 FDA
Patent

US 6723329

Use of parapox B2L protein to modify immune responses to administered antigens

expired A61KA61K2039/55516A61K39/12

Quick answer

US patent 6723329 (Use of parapox B2L protein to modify immune responses to administered antigens) held by The Board of Regents of the University of Texas System expires Mon Apr 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Apr 20 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K2039/55516, A61K39/12, A61K39/275, A61K39/39